Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 62 holding rows worth $126,410,000.

Accession
0001389933-15-000009
Filed
2015-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 62 entries on the cover page, a total value of $126,410,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $126,410,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PHARMACYCLICS INC716933106COM110,928$13,562,000thousands by filing date
ATRICURE INC04963C209COM661,331$13,200,000thousands by filing date
AUSPEX PHARMACE05211J102Common Stock135,885$7,131,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK384,154$6,888,000thousands by filing date
DISCOVERY LABORATORIES INC N254668403COM NEW5,698,739$6,611,000thousands by filing date
INSULET CORP COM45784P101Stock109,418$5,040,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM263,541$4,380,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM634,893$4,044,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM132,442$3,866,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01384,794$3,582,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM21,900$3,416,000thousands by filing date
CTI BIOPHARMA CORP COM NEW12648L106Stock1,425,000$3,363,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/14,000,000$3,200,000thousands by filing dateprincipal
INSULET CORP45784PAD3NOTE 2.000% 6/12,407,000$2,861,000thousands by filing dateprincipal
PROTALIX BIOTHERAPEUTICS INC74365A101COM1,383,889$2,546,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM197,500$2,419,000thousands by filing date
BIOTELEMETRY INC090672106COM235,645$2,364,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK1,374,975$2,035,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock166,656$2,027,000thousands by filing date
MASIMO CORP COM574795100Stock67,500$1,778,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK749,066$1,700,000thousands by filing date
THRESHOLD PHARMACEUTICAL INC885807206COM NEW530,965$1,688,000thousands by filing date
TREVENA INC89532E109COM280,000$1,674,000thousands by filing date
SPECTRANETICS CORP84760C107COM42,162$1,458,000thousands by filing date
Neothetics Inc64066G101COM186,495$1,395,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM23,900$1,338,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM33,466$1,292,000thousands by filing date
NUVASIVE INC670704AC9CORPORATE OBLIG1,000,000$1,289,000thousands by filing dateprincipal
TARGACEPT INC87611R306COM465,293$1,224,000thousands by filing date
VENAXIS INC92262A107COM658,000$1,165,000thousands by filing date
BLUEBIRD BIO INC09609G100COM12,500$1,147,000thousands by filing date
Cynapsus Therapeutics Inc23257Y701COM949,000$1,044,000thousands by filing date
CARDICA INC14141R101COM1,486,004$1,040,000thousands by filing date
UROPLASTY INC917277204COM NEW486,062$1,001,000thousands by filing date
Johnson & Johnson478160104COM9,400$983,000thousands by filing date
CYTRX CORP232828509COM PAR $.001346,400$949,000thousands by filing date
CUTERA INC232109108COM88,694$947,000thousands by filing date
GALMED PHARMACEUTICALS LTDM47238106SHS158,121$917,000thousands by filing date
ENCISION INC29254Q104COM1,062,500$882,000thousands by filing date
XENOPORT INC98411C100COM98,190$861,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD90,947$849,000thousands by filing date
EXACTECH INC30064E109COM31,636$746,000thousands by filing date
AFFIMED N VN01045108COM120,000$744,000thousands by filing date
CAREDX INC14167L103COM87,300$633,000thousands by filing date
INTELLIPHARMACEUTICS INTERNA458173101CMN279,260$631,000thousands by filing date
UNIQURE NVN90064101SHS39,656$587,000thousands by filing date
RTI BIOLOGICS INC74975N105COM85,918$447,000thousands by filing date
GENVEC INC NEW37246C307cs200,000$416,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J100COM39,800$408,000thousands by filing date
LPATH INC-CLASS A548910306CMN121,884$344,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM59,110$297,000thousands by filing date
LUMENIS LTDM6778Q121SHS CL B31,072$290,000thousands by filing date
PROBIODRUG AGBRK8XK3 COM10,500$244,000thousands by filing dateThe CUSIP as filed is malformed.
CYNAPSUS THERAPEUTICS INC23257Y156COM280,769$240,000thousands by filing date
NANOSPHERE INC63009F105COM600,000$235,000thousands by filing date
ESSA PHARMA INC296991474PFD250,000$222,000thousands by filing date
CELSUS THERAPEUTICS PLC15119A202COM43,900$211,000thousands by filing date
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock116,279$191,000thousands by filing date
PROTEON THERAPEUTICS INC74371L109COM12,700$132,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM26,287$103,000thousands by filing date
GLOBEIMMUNE INC37957B100COM10,945$83,000thousands by filing date
INSPIREMD INC45779A309COM63,700$50,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-15-000009this filing2015-02-17acceptance time not in the bulk data set